Aethlon medical publishes preclinical data on the hemopurifier® in transplant immunology journal
Preclinical data suggests expanded therapeutic potential of the hemopurifier® beyond virology and oncology results support further evaluation of the hemopurifier ® as part of a machine perfusion circuit to further assess its impact on the function of retrieved kidneys san diego , march 10, 2025 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases and for use in organ transplantation, today announced the publication of a pre-clinical study in the peer-reviewed journal transplant immunology (https://doi.org/10.1016/j.trim.2025.102215) on february 28, 2025, entitled, " a lectin affinity plasmapheresis device removes extracellular vesicles and micrornas from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys." aethlon medical's hemopurifier® is a therapeutic blood filtration system designed to bind and remove harmful extracellular vesicles and life-threatening viruses from blood and other biological fluids.
AEMD Ratings Summary
AEMD Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission